<VariationArchive RecordType="classified" VariationID="9495" VariationName="NM_005502.4(ABCA1):c.2725del (p.Arg909fs)" VariationType="Deletion" Accession="VCV000009495" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-05-21" MostRecentSubmission="2018-05-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24534" VariationID="9495">
      <GeneList>
        <Gene Symbol="ABCA1" FullName="ATP binding cassette subfamily A member 1" GeneID="19" HGNC_ID="HGNC:29" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="104781006" stop="104928155" display_start="104781006" display_stop="104928155" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="107543282" stop="107690526" display_start="107543282" display_stop="107690526" Strand="-" />
          </Location>
          <OMIM>600046</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005502.4(ABCA1):c.2725del (p.Arg909fs)</Name>
      <CanonicalSPDI>NC_000009.12:104822598:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="104822599" stop="104822599" display_start="104822599" display_stop="104822599" variantLength="1" positionVCF="104822598" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="107584880" stop="107584880" display_start="107584880" display_stop="107584880" variantLength="1" positionVCF="107584879" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R909fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007981.1" sequenceAccession="NG_007981" sequenceVersion="1" change="g.110557del">
            <Expression>NG_007981.1:g.110557del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005502.4" sequenceAccession="NM_005502" sequenceVersion="4" change="c.2725del" MANESelect="true">
            <Expression>NM_005502.4:c.2725del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005493.2" sequenceAccession="NP_005493" sequenceVersion="2" change="p.Arg909fs">
            <Expression>NP_005493.2:p.Arg909fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.107584881del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.107584881del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.104822600del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.104822600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_542" sequenceAccession="LRG_542">
            <Expression>LRG_542:g.110557del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_542t1" sequenceAccession="LRG_542t1">
            <Expression>LRG_542t1:c.2725del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_542p1" sequenceAccession="LRG_542p1" change="p.Arg909fs">
            <Expression>LRG_542p1:p.Arg909fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658657893" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600046.0012" DB="OMIM" />
        <XRef Type="rs" ID="1554714092" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005502.4(ABCA1):c.2725del (p.Arg909fs) AND Tangier disease" Accession="RCV000010103" Version="8">
        <ClassifiedConditionList TraitSetID="2602">
          <ClassifiedCondition DB="MedGen" ID="C0039292">Tangier disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-07-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-07-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-21" MostRecentSubmission="2018-05-21">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11476961</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2602" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6024" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tangier disease</ElementValue>
                <XRef ID="Tangier+disease/6997" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008783" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">High density lipoprotein deficiency, type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">High density lipoprotein deficiency, Tangier type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Analphalipo-proteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha high density lipoprotein deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">A-alphalipoprotein neuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cholesterol thesaurismosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial high density lipoprotein deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Hypoalphalipo-proteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hdl lipoprotein deficiency disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HDLDT1</ElementValue>
                <XRef Type="MIM" ID="205400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TGD</ElementValue>
                <XRef Type="MIM" ID="205400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Tangier disease is characterized by severe deficiency or absence of high-density lipoprotein (HDL) in the circulation resulting in tissue accumulation of cholesteryl esters throughout the body, particularly in the reticuloendothelial system. The major clinical signs of Tangier disease include hyperplastic yellow-orange tonsils, hepatosplenomegaly, and peripheral neuropathy, which may be either relapsing-remitting or chronic progressive in nature. Rarer complications may include corneal opacities that typically do not affect vision, premature atherosclerotic coronary artery disease occurring in the sixth and seventh decades of life (not usually before age 40 years), and mild hematologic manifestations, such as mild thrombocytopenia, reticulocytosis, stomatocytosis, or hemolytic anemia. The clinical expression of Tangier disease is variable, with some affected individuals only showing biochemical perturbations.</Attribute>
                <XRef ID="NBK549920" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7731" />
                <XRef ID="7731" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31751110</ID>
                <ID Source="BookShelf">NBK549920</ID>
              </Citation>
              <XRef ID="31150" DB="Orphanet" />
              <XRef ID="C0039292" DB="MedGen" />
              <XRef ID="MONDO:0008783" DB="MONDO" />
              <XRef Type="MIM" ID="205400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30324" SubmissionDate="2018-02-15" DateLastUpdated="2018-05-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600046.0012_TANGIER DISEASE" title="ABCA1, 1-BP DEL, 2665C_TANGIER DISEASE" />
        <ClinVarAccession Accession="SCV000030324" DateUpdated="2018-05-21" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-07-27">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Lapicka-Bodzioch et al. (2001) developed an assay based on 52 primer sets to amplify all 50 ABCA1 exons and approximately 1 kb of its promoter. The assay allowed for convenient amplification of the gene from genomic DNA and easy mutation analysis through autonomic sequencing. It obviated the need to use mRNA preparations, which were difficult to handle and posed the risk of missing splice junction or promoter mutations. They applied the test to the molecular analysis of a new patient with Tangier disease (TGD; 205400) and found compound heterozygosity for 2 mutations: 2665delC and 4457C-T. These mutations were derived from the father and mother, respectively. The nucleotide substitution caused a ser1446-to-leu substitution (S1446L; 600046.0013). The patient had come to medical attention at the age of 25 years because of splenomegaly and marked reduction of HDL cholesterol as well as ApoA-I and ApoA-II. He had no detectable signs or symptoms of either coronary artery disease or neuropathy.</Attribute>
              <Citation>
                <ID Source="PubMed">11476961</ID>
              </Citation>
              <XRef DB="OMIM" ID="205400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCA1" />
          </GeneList>
          <Name>ABCA1, 1-BP DEL, 2665C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 2665C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600046.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TANGIER DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30324" TraitType="Disease" MappingType="Name" MappingValue="TANGIER DISEASE" MappingRef="Preferred">
        <MedGen CUI="C0039292" Name="Tangier disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

